We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$15.8B
AUM Growth
+$2.12B
Cap. Flow
+$1.31B
Cap. Flow %
8.29%
Top 10 Hldgs %
13.54%
Holding
1,739
New
469
Increased
384
Reduced
350
Closed
529

Sector Composition

Rank Sector Weight
1 Healthcare 19.65%
2 Technology 16.89%
3 Consumer Discretionary 13.55%
4 Industrials 12.67%
5 Financials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRC
26
DELISTED
First Republic Bank
FRC
$79.2M 0.5%
761,942
-118,086
-13% -$11.7M
GD icon
27
General Dynamics
GD
$103B
$77.6M 0.49%
376,810
+369,992
+5,427% +$74.1M
GDDY icon
28
GoDaddy
GDDY
$11.7B
$76.9M 0.49%
1,748,370
-385,800
-18% -$16.6M
FTV icon
29
Fortive
FTV
$18B
$76.1M 0.48%
1,699,726
-1,760,302
-51% -$73.2M
NBIS
30
Nebius Group N.V.
NBIS
$54B
$75.8M 0.48%
2,297,757
+2,248,095
+4,527% +$68.6M
NVDA icon
31
NVIDIA
NVDA
$5.01T
$75.7M 0.48%
16,913,640
+15,867,560
+1,517% +$66M
LVS icon
32
Las Vegas Sands
LVS
$30.6B
$75.6M 0.48%
+1,180,634
New +$73.2M
BIIB icon
33
Biogen
BIIB
$29.8B
$74.9M 0.47%
239,416
-14,608
-6% -$4.33M
NVS icon
34
Novartis
NVS
$292B
$74.6M 0.47%
968,344
-108,536
-10% -$8.2M
CAT icon
35
Caterpillar
CAT
$382B
$73.9M 0.47%
591,434
+287,459
+95% +$33.1M
CSGP icon
36
CoStar Group
CSGP
$12.2B
$73.5M 0.46%
2,740,700
+2,709,900
+8,798% +$75.2M
DAL icon
37
Delta Air Lines
DAL
$60.2B
$73.1M 0.46%
+1,523,510
New +$75.9M
ALSN icon
38
Allison Transmission
ALSN
$9.65B
$71.8M 0.45%
1,888,656
-72,139
-4% -$2.63M
BMY icon
39
Bristol-Myers Squibb
BMY
$134B
$69.3M 0.44%
1,082,328
+851,692
+369% +$49.7M
BSX icon
40
Boston Scientific
BSX
$72B
$69M 0.44%
2,380,934
+197,751
+9% +$5.46M
AVGO icon
41
Broadcom
AVGO
$1.87T
$68.4M 0.43%
2,816,790
+2,501,150
+792% +$61.8M
OXY icon
42
Occidental Petroleum
OXY
$55.2B
$67.3M 0.43%
+1,051,412
New +$64M
A icon
43
Agilent Technologies
A
$39.5B
$66.6M 0.42%
1,040,971
-443,932
-30% -$27.7M
KLAC icon
44
KLA
KLAC
$239B
$66M 0.42%
6,224,580
+4,485,310
+258% +$42.8M
HUM icon
45
Humana
HUM
$45B
$65.4M 0.41%
267,907
-268,451
-50% -$65.8M
J icon
46
Jacobs Solutions
J
$16.4B
$64.7M 0.41%
1,347,821
+577,290
+75% +$25.8M
MSFT icon
47
Microsoft
MSFT
$3.62T
$63.8M 0.4%
862,133
-117,575
-12% -$8.59M
MXIM
48
DELISTED
Maxim Integrated Products
MXIM
$61.8M 0.39%
1,288,374
+817,231
+173% +$37.5M
HSIC icon
49
Henry Schein
HSIC
$9.85B
$61.7M 0.39%
959,826
+340,462
+55% +$23.2M
INTU icon
50
Intuit
INTU
$87.1B
$60.4M 0.38%
425,621
-390,719
-48% -$53.9M

Similar funds

Marshall Wace North America's Q3 2017 Portfolio in Review

As of Q3 2017, Marshall Wace North America held 1,739 positions worth $15.8B, up 16% from $13.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.31B of net new capital in Q3 2017, opening 469 new positions and adding to 384 existing holdings. Its largest new stake was Delta Air Lines: 1,523,510 shares worth $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Terminix Global Holdings, Inc., an estimated $113M trimmed.

  • Marshall Wace North America's largest Q3 2017 buy was Delta Air Lines: 1,523,510 shares worth $73.1M.
  • Marshall Wace North America added most to Johnson & Johnson in Q3 2017, an estimated $260M increase.
  • Marshall Wace North America's biggest Q3 2017 reduction was Terminix Global Holdings, Inc., cutting an estimated $113M.
  • Marshall Wace North America fully exited Reynolds American Inc in Q3 2017, selling an estimated $130M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $15.8B portfolio in Q3 2017.
  • Marshall Wace North America opened 469 new positions and closed 529 in Q3 2017.
  • Marshall Wace North America's portfolio value rose 16% quarter-over-quarter to $15.8B.

Based on Marshall Wace North America's 13F filing for Q3 2017, filed 13 Nov 2017.